Home
Race Oncology Ltd
MD Anderson Preclinical AML Study on Zantrene Published
Business
Feb 23 2022
5 min read

MD Anderson Preclinical AML Study on Zantrene Published

news images

Race Oncology Ltd has released a press release.

View Attachment